Decongestive and protective effects of levosimendan in the critically ill

Dr Alexandre Mebazaa, from the University of Paris in France, discusses the inotropic and decongestive effects of levosimendan in heart failure and cardiogenic shock, in the light of recent studies. Presented during the satellite symposium ‘Securing more time and balance in critical care’ on 22 March 2017 during the 37th ISICEM meeting in Brussels, sponsored by Orion Pharma.


ISICEM 2017 resources

Videos (6)
Login/ Register Maximise Minimise

Alternatively login via